🇺🇸 FDA
Patent

US 9068002

Treatment of multiple sclerosis and/or rheumatoid arthritis

granted A61KA61K2039/505A61P

Quick answer

US patent 9068002 (Treatment of multiple sclerosis and/or rheumatoid arthritis) held by Universität Regensburg expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Universität Regensburg
Grant date
Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61P, A61P19/02, A61P25/00